These results indicate that the pro-survival advantage accompanying the adaptation of heterogeneous melanoma populations to different growth conditions may depend on MCL-1 to a variable extent, and BCL-XL may support its function in these populations in which the contribution of MCL-1 is less pronounced. The gene discussed is BCL2L1; the disease is melanoma.